HFS
ABBV icon

Hantz Financial Services’s AbbVie ABBV Stock Holding History

Hantz Financial Services’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4M Buy
45,381
+685
+2% +$147K 0.15% 87
2026
Q1 		$9.72M Buy
44,696
+1,172
+3% +$260K 0.15% 94
2025
Q4 		$9.95M Sell
43,524
-939
-2% -$214K 0.15% 108
2025
Q3 		$10.3M Buy
44,463
+486
+1% +$99K 0.16% 109
2025
Q2 		$8.16M Sell
43,977
-1,336
-3% -$248K 0.13% 149
2025
Q1 		$9.49M Sell
45,313
-715
-2% -$139K 0.17% 122
2024
Q4 		$8.18M Sell
46,028
-1,817
-4% -$334K 0.14% 154
2024
Q3 		$9.45M Sell
47,845
-1,495
-3% -$279K 0.17% 144
2024
Q2 		$8.46M Sell
49,340
-2,237
-4% -$371K 0.16% 158
2024
Q1 		$9.39M Sell
51,577
-3,384
-6% -$583K 0.18% 144
2023
Q4 		$8.52M Sell
54,961
-3,763
-6% -$549K 0.19% 157
2023
Q3 		$8.75M Buy
58,724
+398
+0.7% +$58.4K 0.22% 137
2023
Q2 		$7.86M Buy
58,326
+157
+0.3% +$23K 0.2% 158
2023
Q1 		$9.27M Buy
58,169
+566
+1% +$86.5K 0.25% 126
2022
Q4 		$9.31M Buy
57,603
+3,718
+7% +$570K 0.28% 118
2022
Q3 		$7.23M Buy
53,885
+1,187
+2% +$170K 0.25% 127
2022
Q2 		$8.07M Buy
52,698
+2,320
+5% +$355K 0.27% 110
2022
Q1 		$8.17M Sell
50,378
-15,940
-24% -$2.32M 0.24% 123
2021
Q4 		$8.98M Sell
66,318
-70
-0.1% -$8.27K 0.26% 111
2021
Q3 		$7.16M Buy
66,388
+9,599
+17% +$1.1M 0.23% 124
2021
Q2 		$6.4M Buy
56,789
+2,702
+5% +$304K 0.23% 118
2021
Q1 		$5.85M Buy
54,087
+17,312
+47% +$1.85M 0.24% 120
2020
Q4 		$3.94M Sell
36,775
-226
-0.6% -$21.7K 0.18% 162
2020
Q3 		$3.24M Sell
37,001
-775
-2% -$73K 0.17% 172
2020
Q2 		$3.71M Buy
37,776
+799
+2% +$70.3K 0.21% 151
2020
Q1 		$2.82M Buy
+36,977
New +$3.15M 0.19% 162

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hantz Financial Services's ABBV Position: Q2 2026 in Review

Hantz Financial Services increased its AbbVie (ABBV) stake by 1.5% in Q2 2026, buying an estimated $147K and bringing the position to 45,381 shares worth $11.4M. The position accounts for 0.15% of the portfolio, ranked #87.

Hantz Financial Services first reported a position in ABBV in Q1 2020 and has held it in 26 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Hantz Financial Services held 45,381 shares of AbbVie worth $11.4M as of Q2 2026.
  • Hantz Financial Services bought 685 AbbVie shares in Q2 2026, an estimated $147K.
  • AbbVie made up 0.15% of Hantz Financial Services's portfolio in Q2 2026, its #87 holding.
  • Hantz Financial Services first reported a position in AbbVie in Q1 2020 and has held it in 26 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.